Number of Companies working on RNAi Based Therapeutics is Exploding!

by Chris on November 3, 2009

in News

AiRNA Pharmaceuticals

Allergan

Alnylam Pharmaceuticals

Benitec

BioCandell Therapeutics

Calando Pharmaceuticals

Cenix BioScience

Cequent Pharmaceuticals

Copernicus Therapeutics

Dicerna Pharmaceuticals

Expression Genetics Corporation

General Research Laboratory

Intradigm Corporation

MDRNA

Mirna Therapeutics

 MiRagen Therapeutics

Nitto Denko Technical Corp

Opko Health

Oxford BioMedica

Polyplus Transfection

Quark Pharmaceuticals

Regulus Therapeutics

RXi Therapeutics

Santaris Pharma

Senesco Technologies

Silence Therapeutics

Siranoamics

siRNAsense A/S

Sylentis Pharmaceuticals

Tacere Therapeutics

Targeted Genetics Corporation

Tekmira Pharmaceuticals Corporation

Incoming search terms for this article:

Related posts:

  1. Marina Biotech Describes Integrated Technology Platform for the Development of RNAi-, microRNA- and Antisense-based Therapeutics
  2. RXi Pharmaceuticals and miRagen Therapeutics Announce Formation of Research Collaboration in the Field of microRNA
  3. Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics
  4. Alnylam Pharmaceuticals & Regulus Therapeutics in the News
  5. RXi Pharmaceuticals Announces Positive Initial Results in microRNA Therapeutics

Tagged as: companies, rnai, therapeutics

Leave a Comment

Previous post:

Next post: